Name :
MGAT1 antibody
Documents :
DataSheet Material Safety Data Sheets (MSDS)
Description :
MGAT1 Rabbit Polyclonal antibody. Positive WB detected in Y79 cells, HepG2 cells. Positive IHC detected in human liver cancer tissue, human heart tissue, mouse heart tissue, mouse liver tissue. Positive IF detected in Hela cells. Observed molecular weight by Western-blot: 51-55 kDa
Tested applications :
ELISA, WB, IHC, IF
Species reactivity :
Human,Mouse,Rat; other species not tested.
Alternative names :
GGNT1 antibody; GlcNAc T I antibody; GLCNAC TI antibody; GLCT1 antibody; GLYT1 antibody; GNT 1 antibody; GNT I antibody; MGAT antibody; MGAT1 antibody
Immunogen :
Isotype :
Rabbit IgG
Preparation :
This antibody was obtained by immunization of MGAT1 recombinant protein (Accession Number: XM_005265916). Purification method: Antigen affinity purified.
Clonality :
Polyclonal
Formulation :
PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage instructions :
Store at -20℃. DO NOT ALIQUOT
Applications :
Recommended Dilution: WB: 1:500-1:5000IHC: 1:20-1:200IF: 1:10-1:100
Background :
MGAT1 represents mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase
References :
Urita A, Matsuhashi T, Onodera T. Alterations of high-mannose type N-glycosylation in human and mouse osteoarthritis cartilage. Arthritis and rheumatism. 63(11):3428-38. 2011. Kippe JM, Mueller TM, Haroutunian V, Meador-Woodruff JH. Abnormal N-acetylglucosaminyltransferase expression in prefrontal cortex in schizophrenia. Schizophrenia research. 166(1-3):219-24. 2015.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Atg12 Mouse mAb In Vitro
Atg12 Mouse mAb web
DM4 Antibody (YA3387): Ravtansine (DM4) is a maytansinoid, a chemical derivative of maytansine being investigated as the cytotoxic payload of a number of antibody-drug conjugates (ADCs). Microtubules are dynamic cytoskeletal polymers that switch stochastically between states of growing and shortening, called “dynamic instability”. They function in the precise segregation of chromosomes during cell division, transport of cellular cargos, and positioning and movement of intracellular organelles. Inhibition of microtubule function leads to cell cycle arrest and cell death. Microtubule-targeted drugs including the Vinca alkaloids, taxanes, and epothilones suppress the dynamic instability of microtubules, induce mitotic arrest, inhibit cell proliferation and induce apoptosis. The anticancer properties of maytansinoids have been attributed to their ability to disrupt microtubule function. The maytansinoid emtansine (DM1), for example, binds at the ends of microtubules and thereby suppress their dynamic instability. It is synthesized in order to link maytansinoids to antibodies via disulfide bonds. Maytansinoids inhibit tubulin polymerization and microtubule assembly and enhance microtubule destabilization, so there is potent suppression of microtubule dynamics resulting in a mitotic block and subsequent apoptotic cell death. DM4 can be used in the preparation of antibody drug conjugate. Although S-methyl DM1 and S-methyl DM4 inhibited microtubule assembly more weakly than maytansine, they suppressed dynamic instability more strongly than maytansine. Like vinblastine, the maytansinoids potently suppress microtubule dynamic instability by binding to a small number of high affinity sites, most likely at microtubule ends. Thus, the maytansine derivatives that result from cellular metabolism of the antibody conjugates are themselves potent microtubule poisons, interacting with microtubules as effectively as or more effectively than the parent molecule.
